Blood test may spot lung cancer early without needles or scans
NCT ID NCT07399210
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test that looks at tiny pieces of DNA (cfDNA) to find out if lung nodules seen on CT scans are cancer or not. Researchers will study 240 adults with small lung nodules to see how accurate the test is. The goal is to avoid unnecessary biopsies or surgeries for harmless nodules.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGMENTOMICS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which lung biopsy method is safer and more accurate?
- Light-Based blood test may spot lung cancer early
- Could a nebulized cocktail make lung scopes less Cough-Inducing?
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
- Can a simple blood test predict leukemia risk after cancer therapy?